<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39499692</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>11</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Oxygen supplementation and cognitive function in long-COVID.</ArticleTitle><Pagination><StartPage>e0312735</StartPage><MedlinePgn>e0312735</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0312735</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0312735</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients can experience persistent cognitive complaints and deficits in long-COVID. Inflammation and capillary damage may contribute to symptoms by interfering with tissue oxygenation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was an exploratory pilot crossover study designed to describe the effects of supplemental oxygen (portable oxygen concentrator, POC) on cognitive performance and peripheral and cerebral oxygen saturation at rest and exercise. Participants with long-COVID (n = 21) were randomized 1:1 to: 1) POC (3h/day) for 2 weeks followed by standard of care (Control) for 2 weeks or 2) Control for 2 weeks then POC (3h/day) for 2 weeks, with a 1-week washout. Cognitive assessment (global cognition [Montreal Cognitive Assessment, MoCA], episodic memory [Hopkins], working memory [Digit Span], executive function [Verbal fluency]) was performed at baseline and after each treatment period. Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder-7 were completed. Peripheral and cerebral oxygen saturation were measured at rest and exercise (treadmill) at baseline and after each treatment period. Statistical analyses were descriptive without formal testing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">MoCA scores were similar under POC (26.45&#xb1;2.31) and Control (26.37&#xb1;2.85); overall POC-Control difference was -0.090 (95% CI [-1.031, 0.850]). Because of a learning effect, post-hoc analyses were performed for Period 1, where the MoCA score difference was 1.705 [0.140, 3.271]. MoCA subscores suggested better performance with POC for Visuospatial/executive (0.618 [-0.106, 1.342]) and Attention (0.975 [0.207, 1.743]). POC trended to have better scores on Digit Span backward (difference: 0.822 [-0.067, 1.711]) and self-reported depressive symptoms (difference: -1.335 [-3.166, 0.495]). For specific PHQ-9 items, POC tended to have lower (better) scores for Q1 (Little interest/pleasure) and Q7 (Trouble concentrating). Cerebral oxygen saturations at end of exercise showed no difference between POC and Control. Peripheral saturations during exercise were similar under POC and Control (difference: 0.519% [-1.675, 2.714]).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An advantage of POC over Control was observed for global cognition, attention, visuospatial/executive performance and depressive symptoms. Results need to be validated in a larger study.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Gagnon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bherer</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayda</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cloutier</LastName><ForeName>Simon-Olivier</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nozza</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Montreal Health Innovations Coordinating Center (MHICC), Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guertin</LastName><ForeName>Marie-Claude</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Montreal Health Innovations Coordinating Center (MHICC), Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaise</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cloutier</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Montreal Health Innovations Coordinating Center (MHICC), Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamada</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Inogen, Goleta, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glezer</LastName><ForeName>Stanislav</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1498-4819</Identifier><AffiliationInfo><Affiliation>Inogen, Goleta, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denault</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tardif</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-8200-8983</Identifier><AffiliationInfo><Affiliation>Montreal Heart Institute, Universit&#xe9; de Montr&#xe9;al, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="Y">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089382" MajorTopicYN="N">Oxygen Saturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: Drs Glezer and Kamada are employees of Inogen. Other authors report no competing interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39499692</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0312735</ArticleId><ArticleId IdType="pii">PONE-D-23-38332</ArticleId><ArticleId IdType="pmc">PMC11537380</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID) [Internet]. 2022. Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition</Citation></Reference><Reference><Citation>Quan M, Wang X, Gong M, Wang Q, Li Y, Jia J. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Lancet Reg Health West Pac. 2023;38:100836. doi: 10.1016/j.lanwpc.2023.100836</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100836</ArticleId><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="pubmed">37457901</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726. doi: 10.14814/phy2.14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Valles-Salgado M, Delgado-&#xc1;lvarez A, Yus M, G&#xf3;mez-Ruiz N, Jorquera M, et al.. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T, Gonevski M, Clark C, Baitule S, Sharma K, Magar A, et al.. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med Lond Engl. 2021;21(6):e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al.. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271&#x2013;278. doi: 10.1016/S1474-4422(19)30368-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30368-0</ArticleId><ArticleId IdType="pmc">PMC7062546</ArticleId><ArticleId IdType="pubmed">31958406</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon C, Olmand M, Dupuy EG, Besnier F, Vincent T, Gr&#xe9;goire CA, et al.. Videoconference version of the Montreal Cognitive Assessment: normative data for Quebec-French people aged 50 years and older. Aging Clin Exp Res. 2022;34(7):1627&#x2013;1633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853900</ArticleId><ArticleId IdType="pubmed">35178685</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, Charbonneau S, Whitehead V, Collin I, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict R, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test- Revised. PARinc; 1991.</Citation><ArticleIdList><ArticleId IdType="pubmed">10726605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. WAIS-IV Wechsler Adult Intelligence Scale. 2008.</Citation></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092&#x2013;1097. doi: 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606&#x2013;613. doi: 10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FVC, Meys R, Delbressine JM, Vaes AW, Go&#xeb;rtz YMJ, van Herck M, et al.. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. 2021;19(1):40. doi: 10.1186/s12955-021-01691-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. The WHO Global Clinical Platform for COVID-19. 2023.</Citation></Reference><Reference><Citation>Trachsel LD, Nigam A, Fortier A, Lalong&#xe9; J, Juneau M, Gayda M. Moderate-intensity continuous exercise is superior to high-intensity interval training in the proportion of VO2peak responders after ACS. Rev Espanola Cardiol Engl Ed. 2020;73(9):725&#x2013;733. doi: 10.1016/j.rec.2019.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2019.09.013</ArticleId><ArticleId IdType="pubmed">31837947</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderone A, Jarry S, Couture EJ, Brassard P, Beaubien-Souligny W, Momeni M, et al.. Early Detection and Correction of Cerebral Desaturation With Noninvasive Oxy-Hemoglobin, Deoxy-Hemoglobin, and Total Hemoglobin in Cardiac Surgery: A Case Series. Anesth Analg. 2022;135(6):1304&#x2013;1314. doi: 10.1213/ANE.0000000000006155</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000006155</ArticleId><ArticleId IdType="pubmed">36097147</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitzky A, Golay M. Smoothing and Differentiation of Data by Simplified Least Squares Procedures. Anal Chem. 1964;36(8):1627&#x2013;1639.</Citation></Reference><Reference><Citation>Fenster BE, Holm KE, Weinberger HD, Moreau KL, Meschede K, Crapo JD, et al.. Right ventricular diastolic function and exercise capacity in COPD. Respir Med. 2015;109(10):1287&#x2013;1292. doi: 10.1016/j.rmed.2015.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2015.09.003</ArticleId><ArticleId IdType="pmc">PMC4745988</ArticleId><ArticleId IdType="pubmed">26371994</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyeington CT, Ancona P, Osawa EA, Cutuli SL, Eastwood GM, Bellomo R. Modern technology-derived normative values for cerebral tissue oxygen saturation in adults. Anaesth Intensive Care. 2019;47(1):69&#x2013;75. doi: 10.1177/0310057X18811962</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X18811962</ArticleId><ArticleId IdType="pubmed">30864480</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra M, Stark J, Dujovny M, Widman R, Ausman JI. Transcranial cerebral oximetry in random normal subjects. Neurol Res. 1998;20(2):137&#x2013;141. doi: 10.1080/01616412.1998.11740496</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.1998.11740496</ArticleId><ArticleId IdType="pubmed">9522349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemmers PMA, van Bel F. Left-to-right differences of regional cerebral oxygen saturation and oxygen extraction in preterm infants during the first days of life. Pediatr Res. 2009;65(2):226&#x2013;230. doi: 10.1203/PDR.0b013e318191fb5d</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/PDR.0b013e318191fb5d</ArticleId><ArticleId IdType="pubmed">18948838</ArticleId></ArticleIdList></Reference><Reference><Citation>Talamonti D, Gagnon C, Vincent T, Nigam A, Lesage F, Bherer L, et al.. Exploring cognitive and brain oxygenation changes over a 1-year period in physically active individuals with mild cognitive impairment: a longitudinal fNIRS pilot study. BMC Geriatr. 2022;22(1):648. doi: 10.1186/s12877-022-03306-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-022-03306-x</ArticleId><ArticleId IdType="pmc">PMC9361664</ArticleId><ArticleId IdType="pubmed">35941561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>